Tocilizumab for Relapsing Polychondritis

Summary

This is a study for one patient with severe relapsing polychondritis which has been unresponsive to other more conventional medications including prednisone, methotrexate, anakinra and TNF inhibitors. Tolerability, and efficacy of the drug, Tocilizumab will be monitored by clinical assessment and bloodwork.

Timeline

Start

2010-05

Primary completion

2010-07

Completion

2012-05

Outcome

Outcome not reported

Stopped: “Tocilizumab was licenced in Canada for children, so the study was not necessary”

Drugs

Indications